Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tomoaki Yoshihara"'
Autor:
Yuki Someya, Hirotaka Watada, Tomoaki Yoshihara, Risa Nakanishi, Akio Kanazawa, Fuki Ikeda, Ruri Sasaki-Omote, Yuka Tosaka, Yoshio Fujitani, Kyoko Kudo-Fujimaki, Tomoya Mita, Koji Komiya, Saeko Kobayashi-Kimura, Takahisa Hirose, Masumi Tanimoto
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Dipeptidyl peptidase-4 inhibitors and glinides are effective in reducing postprandial hyperglycemia. However, little information is available on the comparative effects of the two drugs on the levels of postprandial glucose. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4419d496186e65fa9e321230318e54
https://doi.org/10.1111/jdi.12338
https://doi.org/10.1111/jdi.12338
Autor:
Takuya Takahashi, Hiroshi Fukuda, Yuko Sakurai, Tomoaki Shimizu, Yoshifumi Tamura, Tomoaki Yoshihara, Akio Kanazawa, Risako Yamamoto, Takeshi Ogihara, Takahisa Hirose, Hiroko Abe, Hirotaka Watada, Tomoya Mita, Koji Komiya, Yuichiro Yamashiro, Koji Nomoto, Fuki Ikeda, Minako Kawaguchi, Junko Sato, Yoshio Fujitani, Hiromasa Goto, Takashi Asahara, Satoru Nagata
Publikováno v:
Diabetes Care. 37:2343-2350
OBJECTIVE Mounting evidence indicates that the gut microbiota are an important modifier of obesity and diabetes. However, so far there is no information on gut microbiota and “live gut bacteria” in the systemic circulation of Japanese patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ef75c45ca3e3288fb504a954426e85
https://doi.org/10.2337/dc13-2817
https://doi.org/10.2337/dc13-2817
Autor:
Yuki Someya, Hirotaka Watada, Kyoko Kudo-Fujimaki, Chie Ohmura, Takahisa Hirose, Fumihiko Sato, Yoshio Fujitani, Tomoaki Yoshihara, Akio Kanazawa
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction To investigate the efficacy and safety of vildagliptin, a potent dipeptidyl peptidase-4 inhibitor, as add-on to nateglinide, compared with switching to vildagliptin in Japanese type 2 diabetes patients poorly controlled with nategli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc55ffb9ca90b5520d6ae990b2c8463
https://doi.org/10.1111/jdi.12160
https://doi.org/10.1111/jdi.12160
Autor:
Takahisa Hirose, Masato Iwasaki, Ryuzo Kawamori, Yuki Someya, Hirotaka Watada, Yoshifumi Tamura, Chiharu Ito, Akio Kanazawa, Risako Yamamoto, Tomoaki Yoshihara, Tomoya Mita, Yoshio Fujitani, Fumihiko Sato
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction ‘Morningness’ and ‘eveningness’ represent the sleep–wake patterns of the circadian rhythm might also affect glycemic control in patients with type 2 diabetes. The aim of this study was to examine the relationship between t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe499e853997bf4a0b300bfb9156892
https://doi.org/10.1111/jdi.12047
https://doi.org/10.1111/jdi.12047
Autor:
Yasushi Tanaka, Hirotaka Watada, Chie Ohmura, Yoshio Fujitani, Tomoaki Shimizu, Akio Kanazawa, Ryuzo Kawamori, Takahisa Hirose, Tomoaki Yoshihara, Fuki Ikeda, Kosuke Azuma
Publikováno v:
Endocrine journal. 56(1)
The increased flux of polyol pathway induced by hyperglycemia is implicated in the pathogenesis of various complications associated with diabetic, which results in increased oxidative stress. Because oxidative stress causes tissue damage in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d6614519510dbe23d770eb02885232
https://pubmed.ncbi.nlm.nih.gov/18997444
https://pubmed.ncbi.nlm.nih.gov/18997444
Autor:
Tomoaki Shimizu, Ryuzo Kawamori, Naoki Kumashiro, Yasushi Tanaka, Takahisa Hirose, Hirotaka Watada, Yoshio Fujitani, Yoshie Kanazawa, Tomoaki Yoshihara
Publikováno v:
Endocrine journal. 54(1)
We have previously reported the therapeutic efficacy of mitiglinide combined with once daily insulin glargine (mitiglinide regimen) after switching from multiple daily insulin regimen of aspart insulin and glargine (intensive insulin regimen) in inpa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea25fb73614da8f406809d1afd3f878
https://pubmed.ncbi.nlm.nih.gov/17185877
https://pubmed.ncbi.nlm.nih.gov/17185877
Autor:
Takahisa Hirose, Michiko Abe, Hirotaka Watada, Junko Kawai, Shinya Miwa, Yuka Yamazaki, Yasushi Tanaka, Yuko Sakurai, Kayoko Motojima, Rei Kanno, Yoshie Kanazawa, Fumihiko Sato, Kanako Hara, Hiroshi Uchino, Ken Sakai, Tomoaki Yoshihara, Naoki Kumashiro, Tomoaki Shimizu, Ryuzo Kawamori, Akio Kanazawa, Tomoya Mita
Publikováno v:
Endocrine journal. 53(1)
Mitiglinide is novel class of rapid-acting insulin secretagogues, which have been widely used alone or in combination with other oral hypoglycemic drugs to improve postprandial hyperglycemia in early type 2 diabetes. While mitiglinide enhances postpr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfdc15ef872d48e7cc219cf3f75e2d7e
https://pubmed.ncbi.nlm.nih.gov/16543674
https://pubmed.ncbi.nlm.nih.gov/16543674
Autor:
Junko Sato, Akio Kanazawa, Fuki Ikeda, Tomoaki Yoshihara, Hiromasa Goto, Hiroko Abe, Koji Komiya, Minako Kawaguchi, Tomoaki Shimizu, Takeshi Ogihara, Yoshifumi Tamura, Yuko Sakurai, Risako Yamamoto, Tomoya Mita, Yoshio Fujitani, Hiroshi Fukuda, Koji Nomoto, Takuya Takahashi, Takashi Asahara, Takahisa Hirose
Publikováno v:
Diabetes Care; Aug2014, Vol. 37 Issue 8, p2343-2350, 8p, 4 Charts